Skip to main content
Preprint Credible — Major labs, established NGOs, reputable named-author preprints

Delusions and Harms Associated with AI Chatbot Use: Early Evidence from 185 Real-World Reports

Cross-sectional secondary analysis of 185 deidentified accounts of mental-health harm linked with AI chatbot use (95 first-hand, 90 from relatives, partners or friends) submitted through the web form of the lived-experience group The Human Line Project between 7 August 2025 and 2 February 2026. Paired raters with clinical experience coded delusional beliefs, chatbot validation of beliefs, reasons for use, episode features, outcomes and timing. The authors present the results as preliminary signal detection from a self-selected sample, not as prevalence or causal evidence.

Publisher

arXiv (King's College London Institute of Psychiatry, Psychology and Neuroscience; South London and Maudsley NHS Foundation Trust; The Human Line Project)

Published

7 Sept 2026

Added

today

Key Findings

  • Delusional beliefs were coded as present in 102 of 185 reports (55.1%); among those, the chatbot was described as validating the belief in 50 (49.0%), and belief validation appeared in 59 of all 185 reports (31.9%).
  • Among delusion-positive cases 56.9% involved grandiose and 34.3% persecutory beliefs; the most common theme was belief in AI consciousness (46.1%), followed by religiosity (17.6%), technospiritual or mystical themes (16.7%) and scientific or pseudoscientific discovery (15.7%).
  • Reported outcomes included social isolation (56.8%), relationship breakdown (33.0%) and job loss (16.8%); suicidal ideation was mentioned in 11 reports, death by suicide in 4 (all second-hand) and harm to others in 5; recovery was reported in 8 cases (4.3%).
  • Median age was 35 (IQR 27 to 45); 68.6% of respondents were in North America; ChatGPT was the chatbot in 68.1% of cases (Character.AI 8.1%, Gemini 4.3%, Claude 3.8%, Grok 2.7%); companionship was the most common reason for use (20.0%), then creativity or leisure (19.5%) and emotional support or mental health (18.4%); median length of chatbot use was 12 months (IQR 5 to 24; n = 64).
  • Previous mental illness was reported in 32.4% (psychosis in 5.9%) and a suspected first presentation of new mental illness in 44.9%; loss of insight (40.5%), loss of sleep (15.7%) and compulsive chatbot use (13.0%) were common features; reported harm onset was concentrated in the second and third quarters of 2025, which the authors note coincides with the GPT-4o sycophancy episode and the roll-out of cross-chat memory.
  • Second-hand reports differed sharply from first-hand ones: isolation 53.9 percentage points higher, loss of insight 37.9 points, relationship breakdown 28.9 points and first presentation of new illness 27.3 points, which the authors attribute to informant perspective and case severity.

Methodology Notes

Retrospective, unverified, self-selected convenience sample gathered by a lived-experience advocacy group whose chief executive is a co-author (declared); no denominator, so no prevalence can be derived. Coding by paired raters with clinical experience; agreement statistics reported per variable in the supplement (for example suicidal ideation 96.8% agreement, kappa 0.77). Survey items and a flow diagram are in the supplement; the platform list offered was ChatGPT, Replika, Character.AI, JanitorAI and other. arXiv 2609.08027, version 1 posted 7 September 2026 (announced 9 September), version 2 on 9 September 2026 with text unchanged; 18 pages; not yet peer reviewed (structured JAMA-style abstract suggests journal submission).

Authors

Hamilton Morrin, Vinitha Soundararajan, Thomas Cheliotis-James, Boris Warszawski, Joshua Fakulujo, Zeqi Jia, Etienne Brisson, Thomas A. Pollak

Tags

ai-psychosishuman-line-projectharm-reportskclmaudsleydelusion-validationchatgpt

Cite This

APA

Hamilton Morrin et al. (2026). Delusions and Harms Associated with AI Chatbot Use: Early Evidence from 185 Real-World Reports. arXiv (King's College London Institute of Psychiatry, Psychology and Neuroscience; South London and Maudsley NHS Foundation Trust; The Human Line Project). https://arxiv.org/abs/2609.08027